Crinetics Pharmaceuticals Inc Stock Forecast
Evaluation of Crinetics Pharmaceuticals Inc stock downgraded after the last trading session.
(Updated on Jul 02, 2024)
The Crinetics Pharmaceuticals Inc stock price fell by -1.15% on the last day (Tuesday, 2nd Jul 2024) from $46.07 to $45.54. During the last trading day the stock fluctuated 4.33% from a day low at $45.19 to a day high of $47.15. The price has been going up and down for this period, and there has been a 1.86% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -47 thousand shares and in total, 1 million shares were bought and sold for approximately $56.22 million.
The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Crinetics Pharmaceuticals Inc stock with a 90% probability to be traded between $42.01 and $51.80 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CRNX Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Crinetics Pharmaceuticals Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $46.65. On a fall, the stock will find some support from the short-term average at $44.66. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, July 01, 2024, and so far it has fallen -1.15%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Crinetics Pharmaceuticals Inc stock
Crinetics Pharmaceuticals Inc finds support from accumulated volume at $44.79 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.96 between high and low, or 4.33%. For the last week, the stock has had daily average volatility of 5.58%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CRNX) For The Upcoming Trading Day Of Wednesday 3rd
For the upcoming trading day on Wednesday, 3rd we expect Crinetics Pharmaceuticals Inc to open at $45.96, and during the day (based on 14 day Average True Range), to move between $43.51 and $47.57, which gives a possible trading interval of +/-$2.03 (+/-4.46%) up or down from last closing price. If Crinetics Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 8.92% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $45.58 (0.09%) than the support at $44.79 (1.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Crinetics Pharmaceuticals Inc stock A Buy?
Crinetics Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -2.898 Sell Candidate Downgraded
Predicted Opening Price for Crinetics Pharmaceuticals Inc of Wednesday, July 3, 2024
| Fair opening price July 3, 2024 | Current price |
|---|---|
| $45.96 ( 0.92%) | $45.54 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CRNX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 47.91 | 5.21% |
| R2 | 47.17 | 3.57% |
| R1 | 46.71 | 2.56% |
| Price | 45.54 | |
| S1 | 45.21 | -0.721% |
| S2 | 44.75 | -1.73% |
| S3 | 44.00 | -3.37% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 50.54 | 10.98% |
| R2 | 47.62 | 4.57% |
| R1 | 45.58 | 0.0878% |
| Price | 45.54 | |
| S1 | 44.79 | -1.65% |
| S2 | 44.59 | -2.09% |
| S3 | 42.19 | -7.36% |
FAQ
Click here for our free guide on how to buy Crinetics Pharmaceuticals Inc Stock.
